메뉴 건너뛰기




Volumn 36, Issue 6, 2013, Pages 1493-1499

Clopidogrel responsiveness in patients undergoing peripheral angioplasty

Author keywords

Clopidogrel resistance; Infrainguinal angioplasty; Peripheral arterial disease; Stenting

Indexed keywords

CLOPIDOGREL;

EID: 84888204910     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0577-3     Document Type: Article
Times cited : (27)

References (32)
  • 1
    • 33846497950 scopus 로고    scopus 로고
    • Inter-society consensus for the management of peripheral arterial disease (TASCII)
    • for the TASC II Working Group 10.1016/j.jvs.2006.12.037
    • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, for the TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASCII). J Vasc Surg 45:5-67
    • (2007) J Vasc Surg , vol.45 , pp. 5-67
    • Norgren, L.1    Hiatt, W.R.2    Dormandy, J.A.3    Nehler, M.R.4    Harris, K.A.5    Fowkes, F.G.6
  • 2
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • The clopidogrel in unstable angina to prevent recurrent events trial investigators 10.1056/NEJMoa010746
    • The clopidogrel in unstable angina to prevent recurrent events trial investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502
    • (2001) N Engl J Med , vol.345 , pp. 494-502
  • 3
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • 11520521 10.1016/S0140-6736(01)05701-4 1:CAS:528:DC%2BD3MXmtV2ht7g%3D
    • Mehta SR, Yusuf S, Peters RJ et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527-533
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3
  • 4
    • 27644536235 scopus 로고    scopus 로고
    • Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE post-stenting study
    • 16286165 10.1016/j.jacc.2005.07.041 1:CAS:528:DC%2BD2MXht1SrtbzK
    • Gurbel PA et al (2005) Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE post-stenting study. J Am Coll Cardiol 46:1820-1826
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1820-1826
    • Gurbel, P.A.1
  • 5
    • 29344438894 scopus 로고    scopus 로고
    • Geographical differences in the rates of angiographic restenosis and ischemia- driven target vessel revascularization after percutaneous coronary interventions: Results from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial
    • 16386661 10.1016/j.jacc.2005.07.066
    • Singh M et al (2006) Geographical differences in the rates of angiographic restenosis and ischemia- driven target vessel revascularization after percutaneous coronary interventions: results from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial. J Am Coll Cardiol 47:34-39
    • (2006) J Am Coll Cardiol , vol.47 , pp. 34-39
    • Singh, M.1
  • 6
    • 11844256436 scopus 로고    scopus 로고
    • Variability in platelet responsiveness to clopidogrel among 544 individuals
    • 15653023 10.1016/j.jacc.2004.09.067 1:CAS:528:DC%2BD2MXkvFaitg%3D%3D
    • Serebruany VL, Steinhubl SR, Berger PB et al (2005) Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 45:246-251
    • (2005) J Am Coll Cardiol , vol.45 , pp. 246-251
    • Serebruany, V.L.1    Steinhubl, S.R.2    Berger, P.B.3
  • 7
    • 33749503499 scopus 로고    scopus 로고
    • Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
    • 17005534 10.1093/eurheartj/ehl275 1:CAS:528:DC%2BD28Xht1OksrzF
    • Geisler T, Langer H, Wydymus M et al (2006) Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 27:2420-2425
    • (2006) Eur Heart J , vol.27 , pp. 2420-2425
    • Geisler, T.1    Langer, H.2    Wydymus, M.3
  • 8
    • 33646441600 scopus 로고    scopus 로고
    • Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness
    • von Beckerath N, Pogatsa-Murray G, Wieczorek A et al (2006) Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost 95:910-911
    • (2006) Thromb Haemost , vol.95 , pp. 910-911
    • Von Beckerath, N.1    Pogatsa-Murray, G.2    Wieczorek, A.3
  • 9
    • 33845474736 scopus 로고    scopus 로고
    • Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
    • 16563469 10.1016/j.thromres.2006.01.019 1:CAS:528:DC%2BD2sXhslyrtQ%3D%3D
    • Malinin A, Pokov A, Spergling M et al (2007) Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb Res 119:277-284
    • (2007) Thromb Res , vol.119 , pp. 277-284
    • Malinin, A.1    Pokov, A.2    Spergling, M.3
  • 10
    • 58749094444 scopus 로고    scopus 로고
    • Cytochrome p-450 polymorphisms and response to clopidogrel
    • 19106084 10.1056/NEJMoa0809171 1:CAS:528:DC%2BD1MXhtVSlsbs%3D
    • Mega JL, Close SL, Wiviott SD et al (2009) Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 360:354-362
    • (2009) N Engl J Med , vol.360 , pp. 354-362
    • Mega, J.L.1    Close, S.L.2    Wiviott, S.D.3
  • 11
    • 58749090547 scopus 로고    scopus 로고
    • Genetic determinants of response to clopidogrel and cardiovascular events
    • 19106083 10.1056/NEJMoa0808227 1:CAS:528:DC%2BD1MXhtVSlsbY%3D
    • Simon T, Verstuyft C, Mary-Krause M et al (2009) Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 360:363-375
    • (2009) N Engl J Med , vol.360 , pp. 363-375
    • Simon, T.1    Verstuyft, C.2    Mary-Krause, M.3
  • 12
    • 7544244139 scopus 로고    scopus 로고
    • Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting
    • 15522468 10.1016/j.ehj.2003.10.039 1:CAS:528:DC%2BD2cXptFOgt7c%3D
    • Gorchakova O, von Beckerath N, Gawaz M et al (2004) Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. Eur Heart J 25:1898-1902
    • (2004) Eur Heart J , vol.25 , pp. 1898-1902
    • Gorchakova, O.1    Von Beckerath, N.2    Gawaz, M.3
  • 13
    • 38349065084 scopus 로고    scopus 로고
    • Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: The randomized, double-blind omeprazole clopidogrel aspirin (OCLA) study
    • 18206732 10.1016/j.jacc.2007.06.064 1:CAS:528:DC%2BD1cXpt1Gksg%3D%3D
    • Gilard M, Arnaud B, Cornily JC et al (2008) Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind omeprazole clopidogrel aspirin (OCLA) study. J Am Coll Cardiol 51:256-260
    • (2008) J Am Coll Cardiol , vol.51 , pp. 256-260
    • Gilard, M.1    Arnaud, B.2    Cornily, J.C.3
  • 14
    • 84864685270 scopus 로고    scopus 로고
    • Management of peripheral arterial interventions with mono or dual antiplatelet therapy-The MIRROR study: A randomised and double-blinded clinical trial
    • 22569995 10.1007/s00330-012-2441-2
    • Tepe G, Bantleon R, Brechtel K, Schmehl J, Zeller T, Claussen CD et al (2012) Management of peripheral arterial interventions with mono or dual antiplatelet therapy-the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol 22(9):1998-2006
    • (2012) Eur Radiol , vol.22 , Issue.9 , pp. 1998-2006
    • Tepe, G.1    Bantleon, R.2    Brechtel, K.3    Schmehl, J.4    Zeller, T.5    Claussen, C.D.6
  • 15
    • 84863998168 scopus 로고    scopus 로고
    • ® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention
    • 22811359 10.1002/jcla.21515 1:CAS:528:DC%2BC38XhtVGhs7bF
    • ® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention. J Clin Lab Anal 26(4):262-266
    • (2012) J Clin Lab Anal , vol.26 , Issue.4 , pp. 262-266
    • Jang, J.1    Lim, J.2    Chang, K.3
  • 16
    • 44949173754 scopus 로고    scopus 로고
    • Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
    • 18263931 10.1093/eurheartj/ehn046
    • Price MJ, Endemann S, Gollapudi RR et al (2008) Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29(8):992-1000
    • (2008) Eur Heart J , vol.29 , Issue.8 , pp. 992-1000
    • Price, M.J.1    Endemann, S.2    Gollapudi, R.R.3
  • 17
    • 77953911457 scopus 로고    scopus 로고
    • Working group on high on-treatment platelet reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate
    • 20828644 10.1016/j.jacc.2010.04.047 1:CAS:528:DC%2BC3cXhtlWjt7jJ
    • Bonello L, Tantry US, Marcucci R et al (2010) Working group on high on-treatment platelet reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56(12):919-933
    • (2010) J Am Coll Cardiol , vol.56 , Issue.12 , pp. 919-933
    • Bonello, L.1    Tantry, U.S.2    Marcucci, R.3
  • 18
    • 79951787896 scopus 로고    scopus 로고
    • Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia
    • 21314342 10.1583/10-3242.1
    • Karnabatidis D, Spiliopoulos S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S et al (2011) Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 18(1):1-12
    • (2011) J Endovasc Ther , vol.18 , Issue.1 , pp. 1-12
    • Karnabatidis, D.1    Spiliopoulos, S.2    Diamantopoulos, A.3    Katsanos, K.4    Kagadis, G.C.5    Kakkos, S.6
  • 19
    • 77957754792 scopus 로고    scopus 로고
    • Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: Long-term results from a prospective randomized single-center controlled trial
    • 10.1007/s00270-010-9915-x
    • Spiliopoulos S, Katsanos K, Karnabatidis D, Diamantopoulos A, Kagadis GC, Christeas N et al (2010) Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Interv Radiol 33(5):929-938
    • (2010) Cardiovasc Interv Radiol , vol.33 , Issue.5 , pp. 929-938
    • Spiliopoulos, S.1    Katsanos, K.2    Karnabatidis, D.3    Diamantopoulos, A.4    Kagadis, G.C.5    Christeas, N.6
  • 20
    • 69249211125 scopus 로고    scopus 로고
    • Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: Analysis of long-term angiographic and clinical outcome
    • 19620014 10.1016/j.jvir.2009.05.031
    • Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC et al (2009) Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 20(9):1141-1150
    • (2009) J Vasc Interv Radiol , vol.20 , Issue.9 , pp. 1141-1150
    • Siablis, D.1    Karnabatidis, D.2    Katsanos, K.3    Diamantopoulos, A.4    Spiliopoulos, S.5    Kagadis, G.C.6
  • 21
    • 84857044210 scopus 로고    scopus 로고
    • Antiplatelet and anticoagulant drugs in interventional radiology
    • 10.1007/s00270-011-0204-0
    • Altenburg A, Haage P (2012) Antiplatelet and anticoagulant drugs in interventional radiology. Cardiovasc Interv Radiol 35:30-42
    • (2012) Cardiovasc Interv Radiol , vol.35 , pp. 30-42
    • Altenburg, A.1    Haage, P.2
  • 22
    • 17144370263 scopus 로고    scopus 로고
    • Resistance to clopidogrel: A review of the evidence
    • 15837243 10.1016/j.jacc.2005.01.034 1:CAS:528:DC%2BD2MXjtlagsb8%3D
    • Nguyen TA, Diodati JG, Phar C (2005) Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 45(8):1157-1164
    • (2005) J Am Coll Cardiol , vol.45 , Issue.8 , pp. 1157-1164
    • Nguyen, T.A.1    Diodati, J.G.2    Phar, C.3
  • 23
    • 79960728693 scopus 로고    scopus 로고
    • Impaired inhibition of P2Y (12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention
    • 21524751 10.1016/j.atherosclerosis.2011.03.039
    • El Ghannudi S, Ohlmann P, Jesel L et al (2011) Impaired inhibition of P2Y (12) by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention. Atherosclerosis 217(2):465-472
    • (2011) Atherosclerosis , vol.217 , Issue.2 , pp. 465-472
    • El Ghannudi, S.1    Ohlmann, P.2    Jesel, L.3
  • 24
    • 79961180319 scopus 로고    scopus 로고
    • Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease
    • 21892403 10.3340/jkns.2011.50.1.40
    • Rho GJ, Shin WR, Kong TS, Kim MS, Lee CJ, Lee BH (2011) Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease. J Korean Neurosurg Soc 50(1):40-44
    • (2011) J Korean Neurosurg Soc , vol.50 , Issue.1 , pp. 40-44
    • Rho, G.J.1    Shin, W.R.2    Kong, T.S.3    Kim, M.S.4    Lee, C.J.5    Lee, B.H.6
  • 25
    • 39649097856 scopus 로고    scopus 로고
    • Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting
    • 17989373 10.3174/ajnr.A0818 1:STN:280:DC%2BD1c7htV2isQ%3D%3D
    • Prabhakaran S, Wells KR, Lee VH, Flaherty CA, Lopes DK (2008) Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 29(2):281-285
    • (2008) AJNR Am J Neuroradiol , vol.29 , Issue.2 , pp. 281-285
    • Prabhakaran, S.1    Wells, K.R.2    Lee, V.H.3    Flaherty, C.A.4    Lopes, D.K.5
  • 26
    • 84861344725 scopus 로고    scopus 로고
    • Association of estimated GFR with platelet inhibition in patients treated with clopidogrel
    • 22425260 10.1053/j.ajkd.2011.12.027 1:CAS:528:DC%2BC38Xkt1CqtbY%3D
    • Muller C, Caillard S, Jesel L et al (2012) Association of estimated GFR with platelet inhibition in patients treated with clopidogrel. Am J Kidney Dis 59(6):777-785
    • (2012) Am J Kidney Dis , vol.59 , Issue.6 , pp. 777-785
    • Muller, C.1    Caillard, S.2    Jesel, L.3
  • 27
    • 80053080423 scopus 로고    scopus 로고
    • Variability of clopidogrel response in patients with type 2 diabetes mellitus
    • 10.1177/1479164111420890
    • Hall HM, Banerjee S, McGuire DK (2011) Variability of clopidogrel response in patients with type 2 diabetes mellitus. Diabetes Vasc Dis Res 8(4):245-253
    • (2011) Diabetes Vasc Dis Res , vol.8 , Issue.4 , pp. 245-253
    • Hall, H.M.1    Banerjee, S.2    McGuire, D.K.3
  • 28
    • 84856158305 scopus 로고    scopus 로고
    • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
    • 21873419 10.1093/eurheartj/ehr236
    • Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999-3054
    • (2011) Eur Heart J , vol.32 , pp. 2999-3054
    • Hamm, C.W.1    Bassand, J.P.2    Agewall, S.3
  • 29
    • 79955110460 scopus 로고    scopus 로고
    • Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: The importance of CYP2C19*2 genotyping
    • 21511219 10.1016/j.jcin.2010.12.011
    • Alexopoulos D, Dimitropoulos G, Davlouros P et al (2011) Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping. JACC Cardiovasc Interv 4(4):403-410
    • (2011) JACC Cardiovasc Interv , vol.4 , Issue.4 , pp. 403-410
    • Alexopoulos, D.1    Dimitropoulos, G.2    Davlouros, P.3
  • 30
    • 84863680949 scopus 로고    scopus 로고
    • Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: A pharmacodynamic study
    • 22789884 10.1016/j.jacc.2012.03.050 1:CAS:528:DC%2BC38XhtVCmurfE
    • Alexopoulos D, Galati A, Xanthopoulou I et al (2012) Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. J Am Coll Cardiol 60(3):193-199
    • (2012) J Am Coll Cardiol , vol.60 , Issue.3 , pp. 193-199
    • Alexopoulos, D.1    Galati, A.2    Xanthopoulou, I.3
  • 31
    • 79952048493 scopus 로고    scopus 로고
    • Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
    • 21057581 1:CAS:528:DC%2BC3cXhtlelsbfJ
    • Abergel E, Nikolsky E (2010) Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome. Vasc Health Risk Manag 6:963-977
    • (2010) Vasc Health Risk Manag , vol.6 , pp. 963-977
    • Abergel, E.1    Nikolsky, E.2
  • 32
    • 84861857758 scopus 로고    scopus 로고
    • A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: Results of the TRIGGER-PCI (testing platelet reactivity in patients undergoing elective stent placement on clopidogrel to guide alternative therapy with prasugrel) study
    • 22520250 10.1016/j.jacc.2012.02.026 1:CAS:528:DC%2BC38XosVGrtbw%3D
    • Trenk D, Stone GW, Gawaz M et al (2012) A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (testing platelet reactivity in patients undergoing elective stent placement on clopidogrel to guide alternative therapy with prasugrel) study. J Am Coll Cardiol 59(24):2159-2164
    • (2012) J Am Coll Cardiol , vol.59 , Issue.24 , pp. 2159-2164
    • Trenk, D.1    Stone, G.W.2    Gawaz, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.